Skip to main content

RA Panel Discussion from EULAR 2023

Discussants: Dr. Antoni Chan, Dr. Jonathan Kay, Dr. David Liew, Dr. Jack Cush (moderator)

RheumNow's RA faculty convene to discuss highlight RA abstracts from EULAR 2023, including: 1. TLL-018 vs Tofacitinib in RA 2. Recombinant Zoster vaccination in RA patients on MTX and updacitinib 3. APIPPRA study - ABA vs. PBO in Preclinical RA 4. Continued reliance on Prednisone in RA - POS0319 5. RABBIT Registry: Mortality Risks in RA with ILD 6. Male fertility and MTX use 7. JAK- POT study and CV risk with JAK, TNF or other MOA inhibitors

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×